Matches in Nanopublications for { ?s ?p "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP339837.RADqpndNe5kafXeY5o1ywYBN2A1Th8cz_1aGO3ZYZuXJo130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339837.RADqpndNe5kafXeY5o1ywYBN2A1Th8cz_1aGO3ZYZuXJo130_provenance.
- NP775883.RAj0sVHw3zGq_bjDetHkmpWcAm7qJZBSTZJ3LBjwUempM130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775883.RAj0sVHw3zGq_bjDetHkmpWcAm7qJZBSTZJ3LBjwUempM130_provenance.
- NP331084.RAR9_KumfPKlyJ-28cjw2KTW_pX1IIV59W6LMuUvRyI6Q130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331084.RAR9_KumfPKlyJ-28cjw2KTW_pX1IIV59W6LMuUvRyI6Q130_provenance.
- NP174426.RAygJeNtP6PVAyHCoXsuf0zrDbU9Yrm21nxWOcogSJ3Nw130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174426.RAygJeNtP6PVAyHCoXsuf0zrDbU9Yrm21nxWOcogSJ3Nw130_provenance.
- NP245453.RANccGjLU9dndkDRlZ1ffzcjmHFfaJ2nIwxa0kgnn3mzA130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP245453.RANccGjLU9dndkDRlZ1ffzcjmHFfaJ2nIwxa0kgnn3mzA130_provenance.
- NP176608.RAfLMFa2NM1tMTjPF48kq7LeqpqAqG5n3Humy7WaFiay4130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176608.RAfLMFa2NM1tMTjPF48kq7LeqpqAqG5n3Humy7WaFiay4130_provenance.
- NP686495.RAijujc00DEjhWRuNddyGS7ZBPa_4ikbzSWV3arP2CgPM130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686495.RAijujc00DEjhWRuNddyGS7ZBPa_4ikbzSWV3arP2CgPM130_provenance.
- NP337196.RAPpfLDiI2-Vvi-BR11OYgyJGMxZSe9yAFINqeug5ahW4130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337196.RAPpfLDiI2-Vvi-BR11OYgyJGMxZSe9yAFINqeug5ahW4130_provenance.
- NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905405.RA2D-S4LZoA9TJV4ZjnEurW7_dwOyBLqeR-B77ZhWrJZo130_provenance.
- NP453142.RAIIcrQMsG0WlD2gRLytap2mVv5nur6ufgQXuOlFut4OA130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453142.RAIIcrQMsG0WlD2gRLytap2mVv5nur6ufgQXuOlFut4OA130_provenance.
- NP460604.RAFjwE8IsKqC_MoAazvOSF093gwwLIIzlx7H22A_0p9R4130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460604.RAFjwE8IsKqC_MoAazvOSF093gwwLIIzlx7H22A_0p9R4130_provenance.
- NP781994.RAG_L0ChrerlgwBolPPhdbWiOAkS8heDbFLQpN8bq6IZo130_assertion description "[Moreover, CDDO-Me (7.5 mg/kg/day) also inhibited pancreatic human L3.6pL tumor growth and down-regulated Sp1, Sp3, and Sp4 in tumors using an orthotopic pancreatic cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781994.RAG_L0ChrerlgwBolPPhdbWiOAkS8heDbFLQpN8bq6IZo130_provenance.